Literature DB >> 11064275

Matrix metalloproteinase expression in nonrheumatic aortic stenosis.

M E Edep1, J Shirani, P Wolf, D L Brown.   

Abstract

BACKGROUND: Nonrheumatic aortic stenosis (NAS) is considered to be a degenerative process characterized by valve thickening, fibrocalcific masses, collagen disarray, and an inflammatory infiltrate. The matrix metalloproteinases (MMPs) are a family of zinc- and calcium-dependent enzymes produced by inflammatory cells that are capable of degrading collagen, elastin, and proteoglycans. This study sought to test the hypothesis that MMPs are involved in the pathogenesis of NAS. METHODS AND
RESULTS: Aortic values were obtained from nine patients with NAS undergoing valve replacement and from four patients without NAS during autopsy. Microscopic analysis of NAS specimens revealed variable areas of calcium deposits, fibrosis, and an extensive cellular infiltrate consisting of macrophages, lymphocytes, and fibroblasts. Control aortic valves demonstrated normal architecture, a predominance of fibroblasts, occasional scattered macrophages, and no lymphocytes. Immunohistochemical staining with antibodies to MMP-1, -2, -3 and -9 revealed expression of each enzyme in macrophages, lymphocytes, and fibroblasts of all NAS patients. MMP-1, -2 and -3 were expressed by resident fibroblasts and macrophages in normal valves, but to a lesser degree. MMP-9 was not identified in normal valves.
CONCLUSIONS: The current study confirms an inflammatory infiltrate composed of macrophages and lymphocytes in NAS. Additionally, the increased expression of MMP-1, -2, and -3, along with the unique expression of MMP-9 in NAS valve leaflets was documented. These findings are consistent with the hypothesis that NAS is associated with chronic inflammation and that the increased expression of MMPs may contribute to the pathogenesis of this disease process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064275     DOI: 10.1016/s1054-8807(00)00043-0

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  51 in total

1.  Calcification of bicuspid aortic valves.

Authors:  C M Otto
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

2.  Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.

Authors:  Kana Wakabayashi; Takeshi Tsujino; Yoshiro Naito; Akira Ezumi; Masaaki Lee-Kawabata; Shinji Nakao; Akiko Goda; Yasushi Sakata; Kazuhiro Yamamoto; Takashi Daimon; Tohru Masuyama
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

Review 3.  Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?

Authors:  Yoginee Sritharen; Maurice Enriquez-Sarano; Hartzell V Schaff; Grace Casaclang-Verzosa; Jordan D Miller
Journal:  Physiology (Bethesda)       Date:  2017-05

4.  Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis.

Authors:  B Jian; P L Jones; Q Li; E R Mohler; F J Schoen; R J Levy
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.

Authors:  Jae-Joon Jung; Mahmoud Razavian; Azariyas A Challa; Lei Nie; Reza Golestani; Jiasheng Zhang; Yunpeng Ye; Kerry S Russell; Simon P Robinson; Donald D Heistad; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2015-04-23       Impact factor: 10.057

6.  The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-κB signaling, and inflammatory gene expression in human aortic valve cells.

Authors:  Vishal Patel; Katrina Carrion; Andrew Hollands; Andrew Hinton; Thomas Gallegos; Jeffrey Dyo; Roman Sasik; Emma Leire; Gary Hardiman; Salah A Mohamed; Sanjay Nigam; Charles C King; Victor Nizet; Vishal Nigam
Journal:  FASEB J       Date:  2015-01-28       Impact factor: 5.191

Review 7.  Aortic valve sclerosis as a marker of active atherosclerosis.

Authors:  Kelley R Branch; Kevin D O'Brien; Catherine M Otto
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

Review 8.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

9.  MMP-12-Induced Pro-osteogenic Responses in Human Aortic Valve Interstitial Cells.

Authors:  Xin-Sheng Deng; Xianzhong Meng; Fei Li; Neil Venardos; David Fullerton; James Jaggers
Journal:  J Surg Res       Date:  2018-10-23       Impact factor: 2.192

10.  High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis.

Authors:  Omer Alyan; Fatma Metin; Fehmi Kacmaz; Ozcan Ozdemir; Orhan Maden; Serkan Topaloglu; Ahmet Duran Demir; Zulkuf Karahan; Aziz Karadede; Erdogan Ilkay
Journal:  J Thromb Thrombolysis       Date:  2008-07-12       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.